PAX3-FOXO1-induced transcriptional dysregulation in rhabdomyosarcoma

被引：0
|
作者：
Stevens, Bradley T.
Zhang, Yang
Adkins, Grace E.
Hopkins, Jack D.
Kimbrough, Darden W.
Garcia, Matthew R.
Hatley, Mark E.
Abraham, Brian J.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：3
相关论文
共 50 条
  • [41] PAX3/FOXO1 fusion gene status reveals rhabdomyosarcoma risk stratification
    Miller, Sarah
    PERSONALIZED MEDICINE, 2012, 9 (03) : 323 - 324
  • [42] Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma
    Bohm, Maria
    Wachtel, Marco
    Marques, Joana G.
    Streiff, Natalie
    Laubscher, Dominik
    Nanni, Paolo
    Mamchaoui, Kamel
    Santoro, Raffaella
    Schafer, Beat W.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (11): : 4237 - 4249
  • [43] Zebrafish models of PAX3-FOXO1 pathogenesis reveal novel targets in human rhabdomyosarcoma
    Kendall, Genevieve
    Watson, Sarah
    Xu, Lin
    Tirode, Franck
    Delattre, Olivier
    Amatruda, James
    CANCER RESEARCH, 2016, 76
  • [44] PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis
    Kendall, Genevieve C.
    Watson, Sarah
    Xu, Lin
    LaVigne, Collette A.
    Murchison, Whitney
    Rakheja, Dinesh
    Skapek, Stephen X.
    Tirode, Franck
    Delattre, Olivier
    Amatruda, James F.
    ELIFE, 2018, 7
  • [45] Recurrent (2;2) and (2;8) Translocations in Rhabdomyosarcoma without the Canonical PAX-FOXO1 Fuse PAX3 to Members of the Nuclear Receptor Transcriptional Coactivator (NCOA) Family
    Bridge, J. A.
    Streblow, R.
    Frayer, R. W.
    Dal Cin, P.
    Rosenberg, A.
    Meloni-Ehrig, A.
    Sumegi, J.
    MODERN PATHOLOGY, 2010, 23 : 16A - 16A
  • [46] Recurrent (2;2) and (2;8) Translocations in Rhabdomyosarcoma without the Canonical PAX-FOXO1 Fuse PAX3 to Members of the Nuclear Receptor Transcriptional Coactivator (NCOA) Family
    Bridge, J. A.
    Streblow, R.
    Frayer, R. W.
    Dal Cin, P.
    Rosenberg, A.
    Meloni-Ehrig, A.
    Sumegi, J.
    LABORATORY INVESTIGATION, 2010, 90 : 16A - 16A
  • [47] Histone deacetylase inhibition triggers suppression of the IGF-1R/Akt pathway in rhabdomyosarcoma and Pax3-Foxo1 in alveolar rhabdomyosarcoma
    Wan, X.
    Issak, S.
    Yeung, C.
    McCalla, A.
    Helman, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S40 - S40
  • [48] PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1
    Lacey, Alexandra
    Rodrigues-Hoffman, Aline
    Safe, Stephen
    CANCER RESEARCH, 2017, 77 (03) : 732 - 741
  • [49] PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
    Thalhammer, Verena
    Lopez-Garcia, Laura A.
    Herrero-Martin, David
    Hecker, Regina
    Laubscher, Dominik
    Gierisch, Maria E.
    Wachtel, Marco
    Bode, Peter
    Nanni, Paolo
    Blank, Bernd
    Koscielniak, Ewa
    Schaefer, Beat W.
    CANCER RESEARCH, 2015, 75 (01) : 98 - 110
  • [50] Negative correlation of single-cell PAX3:FOXO1 expression with tumorigenicity in rhabdomyosarcoma
    Regina, Carla
    Hamed, Ebrahem
    Andrieux, Geoffroy
    Angenendt, Sina
    Schneider, Michaela
    Ku, Manching
    Follo, Marie
    Wachtel, Marco
    Ke, Eugene
    Kikuchi, Ken
    Henssen, Anton G.
    Schafer, Beat W.
    Boerries, Melanie
    Wagers, Amy J.
    Keller, Charles
    Hettmer, Simone
    LIFE SCIENCE ALLIANCE, 2021, 4 (09)
12345